Antihemophilic Factor (Recombinant)
Human coagulation factor VIII produced in a human cell line using recombinant DNA technology. No animal or human derived materials are added during the manufacturing process or to the final medicinal product.
Supplied as powder and solvent for solution for injection, with all vial strengths in a 2.5 mL infusion volume and supplied with a pre-filled syringe.1 Available in vials of: 250 IU, 500 IU, 1000 IU, 2000 IU, 2500 IU, 3000 IU and 4000 IU.1
1. NUWIQ Full Prescribing Information. Paramus, NJ: Octapharma; 2015.